More than just a consultant, ExpandPharma will be an extension of your company in Turkey by working as a part of your team and acting on your behalf.
ExpandPharma provides an integrated suite of services and solutions for pharmaceutical companies from strategy to execution.
With a growing population of 85 million, the implementation of universal healthcare coverage, it's competitive location and strong export network, Turkey is one of the world's most promising pharmaceutical markets.
Established in 2014 in İstanbul, ExpandPharma Consulting provides a portfolio of tailor-made solutions to pharmaceutical companies to realize the full potential of their products in Turkey.
The pharmaceutical market in Turkey is one of the largest and fastest growing markets in the Middle East and North Africa region. With a population of more than 80 million, Turkey offers a large and diverse market for pharmaceutical products.
Global pharmaceutical companies are headquartered in Turkey with significant manufacturing operations using Turkey as a hub for access to regional markets. Successful partnerships are formed with local companies to grow in the region, leveraging the experience and networks of local people.
Turkey is a candidate to be one of the global pharma leaders with its competitive position and export network.
Establishment of the local legal entity in Turkey, which is required to have marketing authorization for pharmaceutical products.
Distributorship agreements with local companies for licensing, sale and distribution of the products.
Co-development, contract manufacturing, out-licensing and in-licensing deals with Turkish companies.
Market access includes generating and communicating data for stakeholders involved in drug adoption and financing, and ensuring that products are priced and reimbursed fairly.
Assessing the burden of disease, sizing the market, developing appropriate pricing, measuring the regulatory and policy environment and implementing the most appropriate distribution approach are the major subjects.
Market access options available in Turkey:
Initial market assessment helps with undestanding market and competition.
Points to be considered in pricing in Turkey are government's pricing policies and restrictions, currency fluctuations, customers' solvency, the nature of competition and market entry mode.
In Turkey, most of the prescribed drugs are included in the Social Security Institution (“SSI”) reimbursement list, and the payments for the treatments are fully or partially paid by the SSI. The national health insurance covers more than 98% of the overall population.
We provide following services for Marketing Authorization Applications: